Table 1 Baseline characteristics of the study participants.

From: Lifestyle practices that reduce seasonal PM2.5 exposure and their impact on COPD

Characteristics

N

Age, years (SD)

67.4 ± 9.8

Male, n (%)

94 (90.38)

Smoking status, n (%)

 Never smoker

17 (16.35)

 Ex-smoker

64 (61.54)

 Current-smoker

23 (22.12)

Smoking history (pack-year), mean (SD)

33.73 ± 23.33

mMRC, n (%)

 Grade 1

62 (59.62)

 Grade 2

12 (11.54)

 Grade 3

16 (15.38)

 Grade 4

14 (13.46)

Acute exacerbation history last year

38 (36.54)

Inhaler usage, n (%)

 

 ICS + LABA

21 (20.19)

 LAMA + LABA

33 (31.73)

 LAMA + LABA + ICS

39 (37.5)

 LABA + LAMA + SABA

3 (2.88)

 ICS + LABA + LAMA + SABA

2 (1.92)

 LAMA + SABA

1 (0.96)

 LAMA

2 (1.92)

 ICS + LAMA

1 (0.96)

 Others

2 (1.92)

Lung function, mean (SD)

 PreBD FEV1, L (% predicted)

1.57 ± 0.54 (52.69 ± 17.11)

 PreBD FVC, L (% predicted)

3.30 ± 0.84 (79.64 ± 16.27)

 PostBD FEV1, L (% predicted)

1.62 ± 0.56 (54.53 ± 16.64)

 PostBD FVC, L (% predicted)

3.28 ± 0.86 (80.52 ± 14.48)

CAT score, mean (SD)

17.04 ± 8.65

SGRQ total, mean (SD)

38.43 ± 2.45

R5-R20 (SD)

0.18 ± 0.03

  1. SD standard deviation, mMRC Modified Medical Research Council, ICS inhaled corticosteroid, LABA long-acting beta 2 agonist, BD bronchodilator, FEV1 forced expiratory volume in one second, FVC forced vital capacity, CAT COPD assessment test.
  2. SGRQ St. George’s Respiratory Questionnaire, R5 resistance at 5 Hz, R20 resistance at 20 Hz.